Healthcare and Life Sciences Value & Outcomes Assessment

Thought leadership

Unlocking Value in the Life Sciences

How do Exponent's multidisciplinary teams help define the value proposition for healthcare products?

Our expert consultants have backgrounds in health services research, epidemiology, outcomes research, and decades of experience generating real-world evidence (RWE) on healthcare product effectiveness, safety, and costs throughout development — and we specialize in post-approval requirements.

We help life sciences companies develop global regulatory roadmaps and optimize market exclusivity for drugs and drug-led combination products. Additionally, we help pharmaceutical companies identify, evaluate, and analyze real-world safety data, including published literature, to develop proactive safety strategies or integrated safety summaries that can be used in regulatory submissions.

Capabilities

Our multidisciplinary teams are ready to provide strategy consulting, RWE analysis, and regulatory support to life sciences companies throughout the product lifecycle to meet the needs of global regulators, payers, providers, and patients.

We help life sciences companies derive real-world evidence (RWE) insights from fit-for-purpose real-world data (RWD) for more informed decision-making to bring innovative medicines to market, improve patient outcomes, and fulfill regulatory requirements.
Learn more
Our team helps life sciences companies differentiate their products by evaluating regulatory, human factors, or market adoption strategies intended to facilitate market adoption and accelerate return on investment (ROI). Building on technical assessments and scientific insights, Exponent also helps companies build strategies for reimbursement and to inform pricing negotiations via budget impact or cost-effectiveness models for healthcare payers.
Exponent enables life sciences companies to engage in non-traditional strategic partnerships (e.g., beyond payer/provider partners) intended to gain access to more diverse and inclusive real-world insights, especially for rare diseases and complex indications.
Our expertise includes helping life sciences companies expand diversity initiatives to include underrepresented populations in their clinical trials and RWE studies to strengthen the body of evidence for healthcare products for all relevant populations and improve outcomes for patients, health systems, regulator, and manufacturers.
We partner with life sciences companies to develop and implement digital endpoints from strategy to validation, including regulatory submissions, understanding reimbursement pathways, and choosing the appropriate digital health technology (DHT) for outcome assessment. These services range from identifying the right technology to assessing human factors, clinical viability, maturity, participant usability, and the validity of the resulting data.
Learn more
Our experts can devise an evidenced-based plan that includes RWE strategies and RWD assessment for regulatory submissions based on decades of generating RWE and working on complex regulatory submissions.

Our Capabilities Are Unparalleled

With expertise in over 90 disciplines and hundreds of capabilities, tools, and methodologies — we get to the root of even the most complex challenges and give you the objective answers you need.

Young patient going into MRI machine. Exponent evaluates the safety, performance, biocompatibility of medical technology.

Insights

Portrait of woman operating machines at food factory

Alerts

Related Expertise

Experts

Our global and comprehensive expertise across industries gives us a deep understanding of current challenges, best industry practices, and the implications of emerging technologies.